Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremie Riou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Hepatology|May 20, 2020
Reply to: "Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward"Jeremie Riou, Clemence M Canivet, Jerome Boursier
Microvascular Research|November 7, 2018
Painless local pressure application to test microvascular reactivity to ischemiaSamir Henni, Jeanne Hersant, Laurent Loufrani, et al.
BMJ Open|March 31, 2026
Leadership delegation, team efficacy and resilience in critical care: a simulation-based studyLara Poitrin, Sophie Le Bris, Emmanuel Rineau, et al.
BMJ Open|June 29, 2021
Thromboembolic risk stratification by TRiP(cast) score to rationalise thromboprophylaxis in patients with lower leg trauma requiring immobilisation: a study protocol of the casting stepped-wedge cluster randomised trialDelphine Douillet, Jeremie Riou, Maximilien Thoma, et al.
BMJ Open|February 11, 2021
Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission (POCUSCO): a study protocol of an international studyFrançois Morin, Delphine Douillet, Jean-Francois Hamel, et al.
The American Journal of Cardiology|January 3, 2026
Selective Use of Thromboaspiration in STEMI: CMR Evidence Against Routine PracticeTom Bourcier, Jeremie Riou, Wissam Abi Khalil, et al.
Journal of Hepatology|January 22, 2022
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related eventsJerome Boursier, Hannes Hagström, Mattias Ekstedt, et al.
Frontiers in Immunology|April 8, 2022
Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis DiagnosisBenoit Brilland, Charlotte Boud'hors, Marie-Christine Copin, et al.
Journal of Hepatology|May 19, 2019
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLDJérôme Boursier, Maeva Guillaume, Vincent Leroy, et al.
Blood Cancer Journal|May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-upJerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Hepatology|May 20, 2020
Reply to: "Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward"Jeremie Riou, Clemence M Canivet, Jerome Boursier
Microvascular Research|November 7, 2018
Painless local pressure application to test microvascular reactivity to ischemiaSamir Henni, Jeanne Hersant, Laurent Loufrani, et al.
BMJ Open|March 31, 2026
Leadership delegation, team efficacy and resilience in critical care: a simulation-based studyLara Poitrin, Sophie Le Bris, Emmanuel Rineau, et al.
BMJ Open|June 29, 2021
Thromboembolic risk stratification by TRiP(cast) score to rationalise thromboprophylaxis in patients with lower leg trauma requiring immobilisation: a study protocol of the casting stepped-wedge cluster randomised trialDelphine Douillet, Jeremie Riou, Maximilien Thoma, et al.
BMJ Open|February 11, 2021
Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission (POCUSCO): a study protocol of an international studyFrançois Morin, Delphine Douillet, Jean-Francois Hamel, et al.
The American Journal of Cardiology|January 3, 2026
Selective Use of Thromboaspiration in STEMI: CMR Evidence Against Routine PracticeTom Bourcier, Jeremie Riou, Wissam Abi Khalil, et al.
Journal of Hepatology|January 22, 2022
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related eventsJerome Boursier, Hannes Hagström, Mattias Ekstedt, et al.
Frontiers in Immunology|April 8, 2022
Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis DiagnosisBenoit Brilland, Charlotte Boud'hors, Marie-Christine Copin, et al.
Journal of Hepatology|May 19, 2019
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLDJérôme Boursier, Maeva Guillaume, Vincent Leroy, et al.
Blood Cancer Journal|May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-upJerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Pageof 1